2022, Volume 29, Supplement 2: Whats new in heart failure guidance – a users guide

July 2022 Br J Cardiol 2022;29(suppl 2):S2

What’s new in heart failure guidance – a user’s guide: Introduction

Paul Kalra

Abstract

Heart failure is such a common problem that all healthcare professionals should be familiar with the contemporary management of these patients. When there are delays in making the diagnosis or treatment is not optimised, patients are at risk of premature death, hospitalisation and many suffer impaired quality of life. To improve outcomes for patients with heart failure, it is imperative that the diagnosis is suspected and made as early as possible. Whilst heart failure specialists are integral to the delivery of optimal patient-centred care, every opportunity should be taken to optimise treatment. We can all help make a real difference for patients....

| View

July 2022 Br J Cardiol 2022;29(suppl 2):S3–S6

New developments in the investigations and diagnosis of heart failure

Patricia Campbell

Abstract

This article reviews some of the new concepts, new recommendations, along with changes to recommendations, in the diagnosis and investigation of heart failure (HF) in the European Society of Cardiology (ESC) 2021 Guidelines for the diagnosis and treatment of acute and chronic heart failure, and contrasts these with the 2016 version of the guidelines....

| View

July 2022 Br J Cardiol 2022;29(suppl 2):S7–S12

Drug therapy in heart failure – an update from the 2021 ESC heart failure guideline

Helen Hardy, Paul R Kalra

Abstract

There have been several key developments in heart failure (HF) management since the 2016 European Society of Cardiology (ESC) HF guidelines were published. The updated 2021 ESC HF Guidelines reflect the modern management of the patient with HF, with an emphasis on evidence-based, individualised care. This overview aims to provide clinicians (whether specialist or non-specialist) with a summary of the major update in drug therapy for HF according to the recent 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic HF....

| View

July 2022 Br J Cardiol 2022;29(suppl 2):S13–S16

Guidance on lifestyle, rehabilitation and devices in heart failure patients

Savvas Hadjiphilippou, Rebecca Lane

Abstract

The aim of the updated 2021 European Society of Cardiology (ESC) heart failure guidelines is to help health care professionals manage people with cardiac failure according to the best available evidence. There is now a wealth of clinical trial data to help select the best management to improve outcomes for people with heart failure; for many, it is now both a preventable and treatable condition. This paper reviews the new advice on lifestyle, rehabilitation, remote monitoring, and the use of devices in this patient population....

| View